Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,468.00
+2.00 (0.08%)
Aug 14, 2025, 3:30 PM IST
Mankind Pharma Revenue
Mankind Pharma had revenue of 35.70B INR in the quarter ending June 30, 2025, with 23.40% growth. This brings the company's revenue in the last twelve months to 129.10B, up 21.22% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.
Revenue (ttm)
129.10B
Revenue Growth
+21.22%
P/S Ratio
7.88
Revenue / Employee
4.79M
Employees
26,978
Market Cap
1,017.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Aurobindo Pharma | 320.25B |
| Alkem Laboratories | 133.04B |